The decisions by Pfizer and Merck to share their COVID-19 drug patents stands in stark contrast to the refusal of Pfizer and other vaccine-makers to release their vaccine recipes ...

May 1 (Reuters) - The U.S. Food and Drug Administration on Friday approved Pfizer and Arvinas' breast cancer drug for ...

The decision also marks the FDA’s first approval of a PROTAC therapy, a type of targeted protein-degrading drug. ・The approval is based on a Phase 3 trial, in which Veppanu reduced the risk of disease ...

As more products reach the market, therapy developers partner with researchers and regulators to deliver N-of-1 treatments to patients.

Pfizer announces positive results from phase 3 MagnetisMM-5 study of Elrexfio as monotherapy in adults with relapsed or refractory multiple myeloma: New York Thursday, April 30, 2 ...

Pfizer Inc. (NYSE: PFE) today announced positive topline results from the Phase 3 MagnetisMM-5 study evaluating ELREXFIO® (elranatamab) as monotherapy ...

Pfizer Inc. today announced positive topline results from the Phase 3 MagnetisMM-5 study evaluating ELREXFIO® (elranatamab) as monotherapy in adults with relapsed or refractory multiple myeloma (RRMM) ...

NVO and PFE clash as the obesity market heats up, with shifting strategies, pipeline bets and growth pressures reshaping ...

We take a closer look at Gilead's pipeline strategy and dealmaking activity in 2026 as the company attempts to broaden its ...

A Scottish mum left epileptic from a brain tumour she believes was caused by years of taking the contraceptive jab has joined ...

Lindsay Tinney, 50, took the Depo-Provera shot for seven years before she came off the injection to try for a baby in 2004.

There might be room for two titans in the obesity business, but a third player might have a uniquely marketable option.